ZNF714 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.520390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.865600E-01
Normal-vs-Stage2
1.633960E-01
Normal-vs-Stage3
3.353400E-01
Normal-vs-Stage4
4.030400E-01
Stage1-vs-Stage2
9.062200E-01
Stage1-vs-Stage3
6.213000E-01
Stage1-vs-Stage4
8.398000E-01
Stage2-vs-Stage3
6.618200E-01
Stage2-vs-Stage4
9.078400E-01
Stage3-vs-Stage4
7.703800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.830760E-01
Normal-vs-AfricanAmerican
5.487000E-01
Normal-vs-Asian
3.227400E-01
Caucasian-vs-AfricanAmerican
5.886200E-01
Caucasian-vs-Asian
7.213800E-02
AfricanAmerican-vs-Asian
7.538200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.844400E-01
Normal-vs-Female
2.540600E-01
Male-vs-Female
5.838200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.279600E-01
Normal-vs-Age(41-60Yrs)
2.121800E-01
Normal-vs-Age(61-80Yrs)
1.564000E-01
Normal-vs-Age(81-100Yrs)
4.550800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.626800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.914000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.407820E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.844600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.494400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.599400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.633400E-01
Normal-vs-Daily Drinker
1.364830E-01
Normal-vs-Weekly Drinker
3.596600E-01
Normal-vs-Occasional Drinker
3.879800E-01
Normal-vs-Social Drinker
4.034600E-01
Non Drinker-vs-Daily Drinker
9.006000E-01
Non Drinker-vs-Weekly Drinker
2.264400E-01
Non Drinker-vs-Occasional Drinker
3.525600E-01
Non Drinker-vs-Social Drinker
4.275000E-01
Daily Drinker-vs-Weekly Drinker
3.483800E-01
Daily Drinker-vs-Occasional Drinker
4.940800E-01
Daily Drinker-vs-Social Drinker
4.417400E-01
Weekly Drinker-vs-Occasional Drinker
6.731400E-01
Weekly Drinker-vs-Social Drinker
1.438000E-01
Occasional Drinker-vs-Social Drinker
2.080000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.778560E-01
Normal-vs-Grade 2
8.242100E-02
Normal-vs-Grade 3
1.081030E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.498200E-01
Grade 1-vs-Grade 3
5.929400E-01
Grade 1-vs-Grade 4
1.778560E-01
Grade 2-vs-Grade 3
5.767000E-01
Grade 2-vs-Grade 4
8.242100E-02
Grade 3-vs-Grade 4
1.081030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.249400E-01
Normal-vs-NonDiabetic
1.403560E-01
Diabetic-vs-NonDiabetic
3.022200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.486160E-01
Normal-vs-NoPancreatitis
4.649400E-01
Pancreatitis-vs-NoPancreatitis
4.634400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.496750E-01
Normal-vs-N1
1.775440E-01
N0-vs-N1
3.195200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.687800E-01
Normal-vs-TP53-NonMutant
3.585600E-01
TP53-Mutant-vs-TP53-NonMutant
4.396000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
